GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427401. A total of 41 filers reported holding GENOCEA BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,319,000 | +7.0% | 1,855,112 | -0.7% | 0.00% | – |
| Q4 2021 | $2,167,000 | -42.9% | 1,867,395 | -5.5% | 0.00% | -100.0% |
| Q3 2021 | $3,793,000 | -22.6% | 1,975,326 | -5.7% | 0.00% | 0.0% |
| Q2 2021 | $4,901,000 | -10.0% | 2,094,436 | +4.2% | 0.00% | 0.0% |
| Q1 2021 | $5,448,000 | +17.2% | 2,009,986 | +4.6% | 0.00% | 0.0% |
| Q4 2020 | $4,649,000 | +10.3% | 1,921,032 | +4.3% | 0.00% | 0.0% |
| Q3 2020 | $4,216,000 | +2827.8% | 1,841,203 | +2843.1% | 0.00% | – |
| Q2 2020 | $144,000 | +144.1% | 62,559 | +83.9% | 0.00% | – |
| Q1 2020 | $59,000 | -43.3% | 34,013 | -32.5% | 0.00% | – |
| Q4 2019 | $104,000 | +147.6% | 50,355 | +247.9% | 0.00% | – |
| Q3 2019 | $42,000 | -38.2% | 14,473 | -16.3% | 0.00% | – |
| Q2 2019 | $68,000 | – | 17,290 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $878,000 | 2.94% |
| COMMODORE CAPITAL LP | 2,929,447 | $6,855,000 | 2.39% |
| Polaris Venture Management Co. V, L.L.C. | 197,345 | $462,000 | 0.74% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,972,056 | $4,615,000 | 0.54% |
| BVF INC/IL | 4,012,404 | $9,389,000 | 0.35% |
| NEA Management Company, LLC | 10,376,936 | $24,282,000 | 0.32% |
| Avoro Capital Advisors LLC | 5,084,184 | $11,897,000 | 0.21% |
| Diametric Capital, LP | 69,977 | $164,000 | 0.12% |
| Boxer Capital, LLC | 1,134,453 | $2,655,000 | 0.09% |
| Ikarian Capital, LLC | 200,000 | $468,000 | 0.04% |